The corpus luteum (CL) is an ephemeral tissue that regresses functionally for inducing the next estrous cycle or parturition cascade and structurally for homeostasis of the organ size. The mechanism of its regression varies considerably depending on animal species, spontaneous versus induced ones, and the kinds of luteolytic factors of extra- and intra-luteal origins \[[@r31], [@r32]\]. Death of the tissue-constituting cells, mainly steroidogenic cells and vascular endothelial cells, is a central process of CL regression. Among multiple modes of cell death, apoptosis is the typical and the most characterized one \[[@r16]\]. With the remarkable progress in apoptosis research, a great number of studies both *in vivo* and *in vitro* have focused on the presence of Fas receptor and ligand (FasL) system in CLs and have ascribed this signaling to the putatively common and primary pathway in cell death during structural demise \[[@r32]\].

The luteolytic mechanism including cell death has been most often investigated in rat and mouse models. Four types of CLs of those animals include the ones of the non-fertile cycle (CyCL), pseudopregnancy (PsCL), pregnancy (PrCL) or lactation \[[@r31]\]. RT-PCR and Western blot analyses demonstrated Fas expression in CL tissues/cells \[[@r5], [@r6], [@r18], [@r19], [@r28]\], and immunohistochemistry showed fairly ubiquitous distribution throughout the tissue of CyCL \[[@r29], [@r30]\], PsCL \[[@r5]\], PrCL \[[@r28]\] and gonadotropin-primed CyCL \[[@r4]\]. The level of Fas expression *in vivo* tended to increase with age in CyCL \[[@r29], [@r30]\] and PrCL \[[@r5]\], while it was relatively constant in aging PrCL \[[@r28]\] and bromocryptin- and GnRH-treated PsCL \[[@r6]\]. Studies with cultured CL cells showed that Fas mRNA expression was increased by *in vitro* condition \[[@r18]\] and cytokines \[[@r27]\], unaltered by cytokines \[[@r15]\] or decreased by progesterone (P4) \[[@r18]\]. Findings from those extensive studies collectively mean that the cellular identity and CL age- and activity-related change of Fas expression are variable and not established.

Here, we specify the localization of Fas expression and the cell population that would probably undergo Fas-mediated apoptosis in naturally regressing CLs of rats. By the histological/immunohistochemical approach, we identify cell types of Fas expression, test the effect of CL age on Fas-expressing cell numbers and implicate phagocytes infiltration and inflammatory-like reaction in CL regression. We also compare Fas expression and phagocytes distribution among CyCL, PsCL and PrCL, since few reports have so far addressed the common and different features in the luteolytic mechanism of various types of CLs of a given animal species \[[@r31]\].

MATERIALS AND METHODS {#s1}
=====================

*Materials*: Anti-Fas antibody, its blocking peptide and 5 different kinds of antibodies were purchased commercially ([Supplementary Table 1](#pdf_001){ref-type="supplementary-material"}). Vectastain Elite ABC staining kit was obtained from Vector Laboratories (Burlingame, CA, U.S.A.). All other reagents were of analytical grade.

*Animals and tissue sampling*: Animal handling and experimental procedures were approved by the Committee for Laboratory Animals Care and Use at Kitasato University School of Veterinary Medicine (Approval number, 12--006). Female rats of Wistar-Imamichi strain that were 3\~4 months old, 250\~350 g in weight and showing a regular 4-day estrous cycle were used. Pseudopregnancy was induced by mechanical stimuli of vagina, and the first day of the diestrous smear was designated as day 1 of pseudopregnancy (PSP1). Pregnancy was induced by mating with a fertile male, and the day of fertilization (the estrous smear with sperm) was designated as day 1 of pregnancy (PRG1). The duration of pregnancy was 23 days, and therefore, PRG23 corresponded to day 0 of postpartum (PP0).

During 09:00\~11:00 hr of the day, animals were sacrificed by cervical dislocation under anesthesia, and ovaries were harvested. The ovaries of cycling rats were harvested on the estrus, based on the finding that PRL surge occurring in the proestrous afternoon is a potential inducer of apoptotic changes and macrophage infiltration in CyCLs \[[@r9], [@r22]\]. Pseudopregnant animals were sacrificed on PSP6 (active luteal phase), PSP12 (functionally regressed phase) and PSP15. Pregnant rats were sacrificed on PRG6, PRG15, PRG19, PRG21 and PRG23 (just before delivery or just delivering). Postpartum rats were done on PP0 (just after delivery), PP3 and PP6.

*Immunohistochemsitry*: Expression of Fas, FasL, cleaved caspase-3 (active form), myeloperoxidase (MPO, a neutrophil marker) or CD68 (a monocyte/macrophage marker) in the CLs was analyzed by immunohistochemistry. Ovaries were fixed in Bouin's solution, dehydrated and embedded in paraffin. Samples from more than 3 individual rats in each group were examined. Tissues were serially sectioned (3∼5 *µ*m in thickness), deparaffinized and examined. Endogenous peroxidase activity was quenched by pretreatment with 0.3% H~2~O~2~ in methanol for 30 min. All the following procedures used 0.01 M phosphate buffered saline (PBS) pH 7.5 as the standard aqueous buffer for Fas, MPO and CD68 staining. For staining of FasL and cleaved caspase-3, 0.01 M Tris buffered saline (TBS) pH 7.5 was used instead, and for retrieval of these two antigens, tissue sections were treated with microwave in 10 mM citrate buffer for 10 min followed by treatment with 0.1 mM glycine in TBS for 30 min. Tissue sections were incubated with each specific antibody, whose dilution at use was described in [Supplementary Table 1](#pdf_001){ref-type="supplementary-material"}, at 4°C overnight. Antigen/antibody complexes were visualized with the Vectastain ABC staining kit and 3,3′-diaminobenzidine tetrahydrochrolide as peroxidase substrate. Negative controls were performed with non-immunized mouse IgG. To confirm the specificity of the anti-Fas antibody against Fas especially, an equal volume of the antibody with Fas/Apo1 blocking peptide solution (0.5 mg/m*l*) was incubated at 4°C for 3 hr just before use. All slides were counterstained with hematoxylin.

As signals of Fas immunoreaction were not always present evenly throughout the tissue but often localized densely to several focal sites, the number of all signals was counted throughout cross-sectioned area of each CL and was divided by the area (mm^2^). Much care was taken for CyCLs examination to differentiate into four stages (generations) based on their histological features \[[@r21], [@r30]\] and to exclude the newest CLs that just began to be formed in the morning of the harvest day. As for PsCLs and PrCLs, putative tissues were selected based on the histological feature and evaluated. Five to 9 different ovarian specimens of each group were investigated, and the numbers of CL evaluated were indicated in figure legends.

*Statistical analysis*: All numerical data were presented as mean ± SEM. Differences of the means among groups were analyzed by Tukey-Kramer's multiple comparison test. *P*\<0.05 was considered significant.

RESULTS {#s2}
=======

*Immunohistochemical localization of Fas in CyCLs of the estrous rat*: Fas immunostaining was first validated in the ovary harvested in the estrous morning. In many CyCLs, Fas immunoreactions were evidently and densely detected at multiple focal sites with tissue damage and accumulation of inflammatory cells ([Fig. 1A, 1E and 1G](#fig_001){ref-type="fig"}Fig. 1.Immunolocalization of Fas and related factors in CyCL of the estrous rat. (A) Fas immunostaining in CyCL. (B) Pre-absorption of the antibody with the blocking peptide completely abolished the immunoreaction. (C) Immunoreactive Fas-positive cell types include large (black arrowheads) and small (white arrowheads) luteal cells, capillary endothelial cells (blue arrowheads) and blood derived granulocytes and macrophages (green arrowheads). Positive immunoreactions for FasL (D), Fas (E) and cleaved caspase-3 (F), the most of which were densely scattered in inflammatory-like and fibrotic sites (closed dashed lines in E) in the CyCL. Larger magnification of portions of central zone of D and F was available in [Supplementary Fig. 1A and 1B](#pdf_001){ref-type="supplementary-material"}, respectively, to identify the immunopositive cell types. Associated immunostaining for Fas (G), MPO (H) and CD68 (I) was also abundant to inflammatory-like and fibrotic sites (surrounded by the dashed line in G). Magnification of rectangles with dashed lines in H and I was available in [Supplementary Fig. 2A and 2B](#pdf_001){ref-type="supplementary-material"}, respectively. Scale bars, 50 *µ*m (A, B), 25 *µ*m (C), 100 *µ*m (D--I).). The reaction was less frequently, but evidently scattered in the remaining, seemingly intact sites. These signals were clearly abolished by antibody pre-absorption ([Fig. 1B](#fig_001){ref-type="fig"}). The positive cell types in CyCLs included large and small steroidogenic cells, capillary endothelial cells and leukocytes (granulocytes and macrophages), many of which lost the integrity of plasma and nuclear membranes ([Fig. 1C](#fig_001){ref-type="fig"}).

Adjacent sections of CyCLs were used to investigate whether the detected Fas signals associated or not spatially with FasL and cleaved caspase-3 localization. The immunoreactions of FasL ([Fig. 1D](#fig_001){ref-type="fig"}) were closely associated with the presence of Fas ([Fig. 1E](#fig_001){ref-type="fig"}) at focal sites, probably along the distribution of intra-luteal blood capillaries. FasL immunoreactions were present in blood-derived, non-luteal cells and steroidogenic cells ([Supplementary Fig. 1A](#pdf_001){ref-type="supplementary-material"}). Intra-tissue distribution of immunoreactive cleaved caspase-3 overlapped in large part with that of Fas, with their dominant presence at focal inflammatory-like sites ([Fig. 1F](#fig_001){ref-type="fig"}). Large magnification revealed the cell types possessing the executor caspase as steroidogenic cells, capillary endothelial cells and granulocytes ([Supplementary Fig. 1B](#pdf_001){ref-type="supplementary-material"}). Slighter immunoreactions distributed broadly in remaining luteal cells. The spatial association of a set of FasL/Fas/cleaved caspase-3 was also evident in granulosa cells of an atretic follicle present in the same ovarian specimen (data not shown).

A previous finding that neutrophils and monocytes/macrophages were the most abundant leukocytes in rat CLs \[[@r3]\] led us next to determine their distribution in relation with that of Fas signal. The focal sites with densely scattered immunoreactions of Fas ([Fig. 1G](#fig_001){ref-type="fig"}) also exhibited accumulated signals of MPO-positive cells ([Fig. 1H](#fig_001){ref-type="fig"} and [Supplementary Fig. 2A](#pdf_001){ref-type="supplementary-material"}) and CD68-positive cells ([Fig. 1I](#fig_001){ref-type="fig"} and [Supplementary Fig. 2B](#pdf_001){ref-type="supplementary-material"}). In addition to disappearance of signals after antibody neutralization, these associations of apoptotic and phagocytotic systems increase the validity of the current immunological detection of Fas and cells that would undergo Fas-mediated cell death and their engulfment.

*Fas immunolocalization in regressing PsCL and PrCL*: Next, we determined Fas expression in regressing PsCL and PrCL that had once been functionally activated. In the ovary harvested on PSP15, Fas signals were accumulated to the focal, inflammatory-like regions of degenerating PsCL ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Fas and associated phagocytes distribution in PsCL and PrCL. Immunoreactive Fas signals on PSP15 located frequently at focal sites of inflammatory-like reactions (marked by the dashed lines) in regressed PsCL (A). The signals were present on steroidogenic cells (black arrowhead), endothelial cells (blue arrowhead) and granulocytes (green arrowheads) (B). Fas signals (highlighted with black arrowheads) (C) as well as MPO-positive cells (D) and CD68-positive cells (E) were fairly evenly scattered throughout the PrCL tissue sampled on PP0. Fas signals were present on endothelial cells (blue arrowhead) and migratory cells (green arrowheads), but not steroidogenic cells with intact nuclear structure (black arrowheads) (F). Signals of cleaved caspase-3 in a portion of PrCL were predominant in endothelial cells (blue arrowheads) and absent in steroidogenic cells (black arrowheads) (G). Scale bars, 100 *µ*m (A, C, D, E), 12.5 *µ*m (B, F), 20 *µ*m (G).), similarly to that in CyCL. The immunoreactive cell types were mostly steroidogenic cells with irregular shapes of nuclear structures, almost identical to that in CyCLs ([Fig. 2B](#fig_002){ref-type="fig"}).

In contrast to CyCLs and PsCLs, PrCLs harvested on PP0 did not involve focal inflammatory-like reactions. The absence was also the case at other time points of regression examined. Fas-positive signals ([Fig. 2C](#fig_002){ref-type="fig"} and [Supplementary Fig. 3A](#pdf_001){ref-type="supplementary-material"}) were scattered throughout the tissue and MPO-positive neutrophils ([Fig. 2D](#fig_002){ref-type="fig"} and [Supplementary Fig. 3B](#pdf_001){ref-type="supplementary-material"}) and CD68-positive macrophages ([Fig. 2E](#fig_002){ref-type="fig"} and [Supplementary Fig. 3C](#pdf_001){ref-type="supplementary-material"}) also distributed fairly evenly throughout the tissues. Fas signals existed exclusively in endothelial cells and immune cells ([Fig. 2F](#fig_002){ref-type="fig"}). Hypertrophied steroidogenic cells with intact nuclei structure were negative for Fas. The immunoreactions for cleaved caspase-3 in PrCLs were dominant in endothelial cells, positive but to a lesser extent in leukocytes, and very faint in steroidogenic cells ([Fig. 2G](#fig_002){ref-type="fig"}).

*Age-related dynamics of the number of Fas-positive cells in CLs*: Fas expression was morphometrically evaluated by counting the numbers of Fas-positive cells in three types of CLs under different functional and structural states ([Table 1](#tbl_001){ref-type="table"}Table 1.Age-related changes in the number of Fas-positive cells in 3 types of CLCyCLPsCLPrCLStage19.3 +/− 2.1^a)^ (18)PSP66.0 +/− 3.4^a)^ (11)PRG67.7 +/− 1.9^a,\ b)^ (17)226.9 +/− 3.9^b)^ (34)1228.1 +/− 7.1^b)^ (20)1517.3 +/− 3.4^b)^ (9)310.1 +/− 2.7^a)^ (17)1515.8 +/− 4.6^a,\ b)^ (23)193.3 +/− 1.0^a)^ (16)410.0 +/− 2.7^a)^ (30)216.4 +/− 2.7^a,\ b)^ (17)2328.3 +/− 4.7^c)^ (17)PP323.4 +/− 4.1^b,\ c)^ (27)62.8 +/− 1.3^a)^ (9)Fas antigen was counted in distinct ages of CyCL, PsCL and PrCL and displayed as the number (mean +/−SEM) of positive cells per defined area (/mm^2^) of CL sections. The number in parentheses showed each number of CLs examined that were obtained from 5−9 ovarian specimens. Different alphabetical letters in the superscript within the same row mean significant differences among the stages of each CLs (*P*\<0.05).).

In CyCLs, multiple focal sites with inflammatory-like and degenerative reactions were evident in the stage 2 of CLs, where Fas expression was marked ([Fig. 1A, 1E and 1G](#fig_001){ref-type="fig"}). The number of Fas-positive cells in the newest CLs (stage 1) was 9.3 ± 2.1 /mm^2^, and it showed a 2.9 fold-increase (*P*\<0.05) in the stage 2. The number decreased in the stage 3 as the inflammatory-like reaction turned to resolution. It remained low in the last stage as the resolution of inflammation-like reaction and fibrotic replacement were almost completed. This stage-related change in Fas expression is similar to those of inflammation-associated infiltration of neutrophils and macrophages described in our previous report \[[@r21]\].

In PsCLs, the number of Fas-positive cells increased from 6.0 ± 3.4 /mm^2^ on PSP6 to 28.1 ± 7.1 on PSP12 (*P*\<0.05) ([Table 1](#tbl_001){ref-type="table"}). The value decreased on PSP15 to the level insignificantly different from both of those on PSP6 and PSP12.

In PrCLs, the number of Fas expressing cells was 7.7 ± 1.9/mm^2^ on PRG6 and increased significantly on PRG15 ([Table 1](#tbl_001){ref-type="table"}) when P4 secretory function was further potentiated. The value once declined to the basal level on PRG19 and PRG21 and increased drastically on PP0 (a 4.4 fold-increase from PRG21, *P*\<0.05). It remained elevated on PP3 and decreased to the basal level on PP6 (*P*\<0.01).

DISCUSSION {#s3}
==========

We here have specified and localized the cells expressing immunoreactive Fas in naturally regressing CLs of rats. Histological evidence supports the good spatial association of those Fas-positive cells with apoptotic (FasL and active casapse-3) and phagocytotic (macrophages and neutrophils) machineries. The comparative study has revealed that PrCL shows the unique features in steroidogenic cell Fas expression and occurrence of inflammatory-like reaction, both of which are different from those in CyCL and PsCL.

Several reports on Fas immunohistochemistry of rat and mouse ovaries have been so far available, but all of those prepared the negative control groups by replacement with non-specific antibody or the omission of the primary antibody. The currently prepared negative control (the antibody neutralization) is the most appropriate one, warranting the more reliability of Fas detection. Rat CL cells possessing Fas immunoreactivity *in vivo* include steroidogenic cells and vascular endothelial cells mainly, and granulocytes additionally \[[@r2]\]. In the term of the cell types, our data are largely consistent with previous reports on Fas immunohistochemistry of rat and mouse CyCLs \[[@r15], [@r29], [@r30]\]. Intra-tissue distribution and aging-related changes of Fas expression are, however, distinct from those in previous reports. Frequent and focal occurrence of Fas-expressing cells at multiple sites and the temporal increase in Fas-positive cells' number are common characteristics in CyCLs and PsCLs. This feature of spatial distribution of Fas is well consistent with and strongly supported by morphologic assessment of apoptosis in naturally regressing CyCLs \[[@r14], [@r15], [@r17]\] and PsCLs \[[@r12], [@r13]\] using the terminal deoxynucleotidyl transferase nick end labeling (TUNEL) method.

One important finding of this study is the probable lack of Fas expression specifically in steroidogenic cells of PrCLs. This might coincide with the previously reported \[[@r5], [@r25]\] and currently confirmed fact that the effecter caspase-3 was present in steroidogenic cells at the lesser amount than that in endothelial cells. Furthermore, not a few studies *in vivo* have presented evidence for vague or modest apoptotic signs of DNA fragmentation in steroidogenic cells of peri-parturient PrCLs \[[@r5], [@r11], [@r20], [@r25], [@r33]\]. Evidence *in vitro* that rat PrCL isolated before and after parturition represented DNA fragmentation following serum deprivation \[[@r1], [@r11]\] does not mean its actual occurrence *in vivo*. Taken with the consideration of evident Fas expression in steroidogenic cells in CyCL and PsCL, an unknown mechanism associated with further activation of PrCL in the second half of pregnancy \[[@r31]\] may protect steroidogenic cells specifically from Fas expression. Action of sole P4 is unlikely responsible, because steroidogenic cells expression of Fas occurred in PsCL. Previous studies have shown enhanced expression and activity of caspase-3 and its up-stream caspases-2, -8 and -9 in rat PrCL tissue at term \[[@r25], [@r33]\]. It may be possible that a non-Fas death signal, tumor necrosis factor (TNF) α shown to be expressed in steroidogenic cells in PrCL \[[@r1]\] causes caspase-3 activation, but not reaching to DNA degradation *in vivo*. We found marked presence of cytoplasmic vacuole and seemingly intact nuclei in steroidogenic cells of PrCL previously \[[@r20]\] and here again. PrCL regression is likely to involve cell-type-dependent different modes of cell death.

Spatio-temporally matched appearance of Fas-positive cells in regressing CLs strongly suggests Fas expression as a critical regulatory component of regression. Previous reports with a variety of CLs models \[[@r5], [@r6], [@r15], [@r17], [@r28]\] demonstrated that FasL, rather than Fas, was more actively regulated and thus was more responsible for FasL/Fas-mediated apoptotic signaling during regression. However, our quantitative data of Fas expression correlated temporally with TUNEL-sensitive apoptosis in CyCL \[[@r9], [@r22]\] and PrCL \[[@r11], [@r20], [@r25], [@r33]\], suggesting an active role of Fas. This study does not identify what regulates Fas expression in regressing CL. P4 suppressed Fas mRNA expression in steroidogenic cells from rat \[[@r19]\] and bovine \[[@r23]\] CLs *in vitro*. *In vivo* this steroid inhibited apoptosis induction in postpartum rat PrCL \[[@r10], [@r11]\], but facilitated PRL-induced apoptosis in rat CyCL \[[@r8], [@r26]\]. In our experiments of modulation of P4 synthesis or action by local administration of P4, RU486 or trilostane *in vivo,* there were no alterations in Fas expression in CyCL, PsCL and PrCL (data not shown). The discrepancies between *in vivo* and *in vitro* studies and among different CLs models suggest the complex mechanism elaborated through the synthesis and action (sensitivity) of P4. They may also be related partly to the differential indices of determining Fas expression between previous studies \[[@r19], [@r23]\] (RT-PCR analysis on purified steroidogenic cells) and ours (morphometric counting of all cell types positive for Fas).

Distribution of FasL was similar to that of Fas in regressing CyCLs, but the cell types expressing FasL are not sufficiently solved in this study. Kuranaga *et al.* \[[@r17], [@r18]\] documented CD3-positive T lymphocytes as an effecter of PRL-stimulated FasL expression and its induction of Fas-mediated apoptosis of steroidogenic cells in a rat CyCL model. Previous studies with other types of rat CLs \[[@r5], [@r28], [@r30]\] and this study ([Supplementary Fig. 1A](#pdf_001){ref-type="supplementary-material"}), however, strongly suggest that FasL-expressing cells are not such lymphocytes exclusively. To clarify the source, expressional regulation and functional interaction with Fas of FasL are essential to further understand Fas-mediated cell death occurring in regressing CL.

Similar distribution of accumulated neutrophils/macrophages and Fas expression in any types of regressing CLs is significant. These data support the general concept that phagocytes are actively recruited into impaired region(s) of regressing CLs and contribute to tissue destroy and remodeling through secreting cytotoxic TNFα and interferon γ, killing and engulfing cells and debris, and secreting extracellular matrix proteases \[[@r14], [@r15], [@r24]\]. Accumulation of phagocytes at multiple foci in CyCL and PsCL represents a typical inflammatory-like feature, whereas their distribution evenly throughout PrCL tissue does a distinct ("non-focal" and "mild") inflammatory feature. This is, as far as we know, the first indication of the spatial nature of Fas expression and immune cells distribution in regressing CL and of CL type-dependent difference. Furthermore, the occurrence of Fas-positive cell in PrCL is also similar to the temporal alteration in infiltrated neutrophils and macrophages (our unpublished data), suggesting a shared local regulation of Fas expression and phagocytes mobilization. Our effort is now made to study some unique features exhibited by rat PrCL in the latter half of pregnancy and postpartum.

In summary, this study reveals a part of the nature of Fas expression in rat CL. Findings on Fas expression by multiple cell types in a spatio-temporally regulated manner provide further insight into the luteolytic mechanism involving Fas-related cell death and phagocytes-associated inflammatory-like response. Their differences among the CL types within a species make us recognize again the diverse regulatory mechanism of mammalian CL. In many experimental models as well as CLs, different methods of apoptosis detection and data evaluation have produced so variable results and conclusions \[[@r16]\]. The cell death mechanism during CL regression should be searched further and again with the aid of more advanced knowledge and methodology on apoptosis and other modes of cell death \[[@r7], [@r16]\].
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